In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
about
The early stage of the atrial electroanatomic remodeling as substrates for atrial fibrillation in hypertensive patients.The effects of magnesium on the course of atrial fibrillation and coagulation in patients with atrial fibrillation undergoing mitral valve annuloplastyEffects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction.Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.Association of early adult modifiable cardiovascular risk factors with left atrial size over a 20-year follow-up period: the CARDIA studyUpstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.What do we actually know about the relationship between arterial hypertension and atrial fibrillation?Can dabigatran improve blood pressure control?Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network.Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.Consensus document on hypertension and cardiac arrhythmias.Electrocardiographic detection of hypertensive left atrial enlargement in the presence of obesity: re-calibration against cardiac magnetic resonance.Left atrial enlargement: a prevalent marker of hypertensive heart disease.
P2860
Q35070854-78BF172B-1FE5-4199-8AF3-F7162C54666CQ35406672-34035DC9-2261-491B-BA5E-9B5E486E62D9Q37295191-72002EF0-1981-4660-A4FA-9C056E836881Q37496071-94555D00-C71A-4FA7-9B7A-302587E692FCQ37517267-294A6032-AB0F-4F12-B801-D7406C5838D7Q37846370-140B29F8-53B0-47E0-A322-DE94DCD34F14Q37868371-D5C30253-E8AA-4B58-B810-C52C2810C369Q37963121-FB199897-941E-45EB-8C19-B87ADF680C93Q37997994-170EC52C-E6F5-47A3-88D7-D4844DEB3F3FQ38124318-6A957282-7C04-4893-816D-A15156DAC7C2Q39419954-38BBF2D3-8F51-4723-BBE9-8D74B8E1586CQ39773724-5A68B4D7-224C-4A86-B97C-91E6DC15CE33Q46512793-2AC1DA7A-B40B-4ADC-AA18-E0D469CC6D76Q50042165-DA8AC82C-89BA-400B-86B6-58E8B8B7EB33Q53032600-442E98B9-1145-49A2-B9C8-79553934A63BQ54485627-0C337DBE-D1D1-455C-A59C-171A179B81C3
P2860
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@en
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@nl
type
label
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@en
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@nl
prefLabel
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@en
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@nl
P2093
P2860
P50
P1433
P1476
In-treatment reduced left atri ...... r hypertrophy: The LIFE Study.
@en
P2093
Eva Gerdts
Gerard P Aurigemma
Jens E Rokkedal
Kristian Wachtell
Markku S Nieminen
Michael Hecht Olsen
Peter M Okin
P2860
P304
P356
10.3109/08037051.2010.481811
P577
2010-06-01T00:00:00Z